Table 3 Maternal Condition in The Third Trimester, According to Study Group
From: Maternal and infant outcomes during the COVID-19 pandemic: a retrospective study in Guangzhou, China
Maternal condition | 24 January – 31 March 2020 (n = 589) | 24 January – 31 March 2019 (n = 733) | P Value |
|---|---|---|---|
Gestational diabetes | |||
WhiteA1 | 39/589(6.62) | 66/733(9.00) | 0.11 |
WhiteA2 | 10/589(1.70) | 20/733(2.73) | 0.21 |
Pregnancy with obesity | 62/589(10.53) | 69/733(9.41) | 0.50 |
Hepatitis B | 37/589(6.28) | 51/733(6.96) | 0.63 |
PCOS | 1/589(0.17) | 1/733(0.14) | 1.00 |
Scarred uterus | 97/589(16.47) | 128/733(17.46) | 0.63 |
Uterine fibroids | 22/589(3.74) | 32/733(4.37) | 0.56 |
Preeclampsia | 2/589(0.34) | 7/733(0.95) | 0.31 |
Placenta implantation | 2/589(0.34) | 2/733(0.27) | 1.00 |
Placenta previa | 5/589(0.85) | 5/733(0.68) | 0.73 |
Vaginitis | 18/589(3.06) | 26/733(3.55) | 0.62 |
BGS infection | 5/589(0.85) | 7/733(0.95) | 0.84 |
Hypothyroidism | 25/589(4.24) | 29/733(3.96) | 0.79 |
Pregnancy with thrombocytopenia | 2/589(0.34) | 2/733(0.27) | 1.00 |
ICP | 11/589(1.87) | 12/733(1.64) | 0.75 |